Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

    Get Diamond plan for FREE

    logo

    Flora Growth Corp. (FLGC)

    Price:

    20.21 USD

    ( + 1.43 USD)

    Your position:

    0 USD

    ACTION PANEL
    CREATE A NOTE
    ABOUT
    Symbol
    FLGC
    Name
    Flora Growth Corp.
    Industry
    Drug Manufacturers - Specialty & Generic
    Sector
    Healthcare
    Price
    20.210
    Market Cap
    11.695M
    Enterprise value
    491.648M
    Currency
    USD
    Ceo
    Clifford A. Starke
    Full Time Employees
    64
    Ipo Date
    2021-05-11
    City
    Toronto
    Address
    365 Bay Street

    Check the

    KEY TAKEAWAYS

    ASK OUR AI ABOUT THE COMPANY (REGISTER FOR EARLY ACCESS)
    Descriptive alt text

    (REGISTER FOR EARLY ACCESS) CHOOSE A PROMPT ABOVE TO ASK OUR AI ABOUT THE SPECIFIC INFORMATION

    SIMILAR COMPANIES STI SCORE

    Similar STI Score

    Amneal Pharmaceuticals, Inc.

    VALUE SCORE:

    5

    Symbol
    AMRX
    Market Cap
    2.960B
    Industry
    Drug Manufacturers - Specialty & Generic
    Sector
    Healthcare

    2nd position

    Amphastar Pharmaceuticals, Inc.

    VALUE SCORE:

    10

    Symbol
    AMPH
    Market Cap
    1.377B
    Industry
    Drug Manufacturers - Specialty & Generic
    Sector
    Healthcare

    The best

    Lantheus Holdings, Inc.

    VALUE SCORE:

    11

    Symbol
    LNTH
    Market Cap
    3.835B
    Industry
    Drug Manufacturers - Specialty & Generic
    Sector
    Healthcare
    FUNDAMENTALS
    P/E
    -13.301
    P/S
    0.223
    P/B
    43.221
    Debt/Equity
    1.932
    EV/FCF
    -1.967
    Price to operating cash flow
    -1.000
    Price to free cash flow
    -1.000
    EV/sales
    0.344
    Earnings yield
    -0.075
    Debt/assets
    0.343
    FUNDAMENTALS
    Net debt/ebidta
    -0.521
    Interest coverage
    -36.267
    Research And Developement To Revenue
    0.009
    Intangile to total assets
    0.327
    Capex to operating cash flow
    -0.012
    Capex to revenue
    0.002
    Capex to depreciation
    0.135
    Return on tangible assets
    -0.857
    Debt to market cap
    0.665
    Piotroski Score
    2.000
    FUNDAMENTALS
    PEG
    -3.148
    P/CF
    -19.228
    P/FCF
    -1.278
    RoA %
    -57.674
    RoIC %
    -101.700
    Gross Profit Margin %
    21.374
    Quick Ratio
    0.608
    Current Ratio
    0.956
    Net Profit Margin %
    -24.961
    Net-Net
    -1.273
    FUNDAMENTALS PER SHARE
    FCF per share
    -1.064
    Revenue per share
    6.087
    Net income per share
    -1.519
    Operating cash flow per share
    -1.051
    Free cash flow per share
    -1.064
    Cash per share
    0.171
    Book value per share
    0.468
    Tangible book value per share
    -0.394
    Shareholders equity per share
    0.468
    Interest debt per share
    0.946
    TECHNICAL
    52 weeks high
    82.290
    52 weeks low
    15.150
    Current trading session High
    21.010
    Current trading session Low
    19.745
    DIVIDEND
    Dividend yield
    0.00%
    Payout ratio
    0.00%
    Years of div. Increase
    0
    Years of div.
    0
    Q-shift
    Dividend per share
    0
    SIMILAR COMPANIES
    logo

    Country
    CA
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.101
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.502
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.000
    logo

    Country
    US
    Sector
    Consumer Cyclical
    Industry
    Apparel - Retail
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -2.041
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.686
    logo

    Country
    IL
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -5.137
    logo

    Country
    CA
    Sector
    Healthcare
    Industry
    Drug Manufacturers - Specialty & Generic
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.000
    logo

    Country
    US
    Sector
    Communication Services
    Industry
    Broadcasting
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    3.436
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.520
    logo

    Country
    US
    Sector
    Healthcare
    Industry
    Biotechnology
    Dividend yield
    0%
    Payout Ratio
    0%
    P/E
    -0.004
    DESCRIPTION

    Flora Growth Corp., together with its subsidiaries, engages in the growth, cultivation, and development of medicinal cannabis and medicinal cannabis derivative products to pharmacies, medical clinics, and cosmetic companies worldwide. It cultivates, processes, and supplies medicinal-grade cannabis oil, and cannabis derived medical and wellness products; offers skincare and beauty products; develops plant-based and medical-grade pharmaceuticals, phytotherapeutics, and dietary supplements; and designs and markets loungewear made from hemp-derived fabric and materials. The company also manufactures, distributes, and retails cannabidiol (CBD) derived products, such as gummies, topicals, tinctures, and vape products; lifestyle wellness products, including edibles, bath and body, pets, sports recovery, etc.; provides cannabis consumption accessories, personal storage, and travel accessories for vape and dry herb categories; and offers juices, exotic fruits coated with chocolate, and chocolate bars, as well as dried fruits, beans, and pulp from Amazonian fruits in supermarkets, discount retailers, coffee shops, restaurants, and airports. In addition, it engages in the manufacturing, promotion, and distribution of beverage products; manufacture and sale of product formulations for pain relief; and development of pharmaceutical cannabinoid formula for the prevention of Sars-Cov-2. The company sells its products under the JustCBD, Vessel, Mind Naturals, Mambe, Stardog, Tonino Lamborghini, and Kalaya brands. Flora Growth Corp. was incorporated in 2019 and is headquartered in Toronto, Canada.

    NEWS
    https://images.financialmodelingprep.com/news/flora-regains-compliance-with-nasdaq-minimum-bid-requirement-20250820.jpg
    Flora Regains Compliance with NASDAQ Minimum Bid Requirement

    newsfilecorp.com

    2025-08-20 08:31:00

    Fort Lauderdale, Florida--(Newsfile Corp. - August 20, 2025) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is pleased to announce that on August 19, 2025, it has received notice from The Nasdaq Stock Market, LLC ("Nasdaq") stating that the Company has regained compliance with the minimum bid price requirement set forth in Rule 5550(a)(2) of the Nasdaq Listing Rules (the "Minimum Bid Price Requirement"). Flora is now in compliance with all applicable listing standards and will continue to be listed and traded on Nasdaq.

    https://images.financialmodelingprep.com/news/flora-growth-corp-flgc-reports-q2-loss-tops-revenue-20250801.jpg
    Flora Growth Corp. (FLGC) Reports Q2 Loss, Tops Revenue Estimates

    zacks.com

    2025-08-01 18:16:05

    Flora Growth Corp. (FLGC) came out with a quarterly loss of $0.11 per share versus the Zacks Consensus Estimate of a loss of $0.06. This compares to a loss of $0.22 per share a year ago.

    https://images.financialmodelingprep.com/news/flora-growth-corp-announces-1for39-share-consolidation-20250731.jpg
    Flora Growth Corp. Announces 1-for-39 Share Consolidation

    newsfilecorp.com

    2025-07-31 08:01:00

    Fort Lauderdale, Florida--(Newsfile Corp. - July 31, 2025) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company"), today announced that it will effect a 1-for-39 share consolidation of the Company's issued and outstanding common shares (the "Share Consolidation"). The Share Consolidation will be effective at 5:00 p.m.

    https://images.financialmodelingprep.com/news/flora-growth-announces-results-of-2025-annual-and-special-20250630.jpg
    Flora Growth Announces Results of 2025 Annual and Special Meeting of Shareholders

    newsfilecorp.com

    2025-06-30 14:01:00

    Fort Lauderdale, Florida--(Newsfile Corp. - June 30, 2025) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") held its 2025 Annual and Special Meeting of Shareholders (the "Annual Meeting"). The final voting results of the proposals submitted to a vote of the Company's shareholders at the Annual Meeting are as follows: Proposal 1: Election of five directors to the board of directors of the Company (the "Board") to hold office until the Company's 2026 Annual Meeting of Shareholders or until their respective successors are elected or appointed: Broker Director For Against Abstentions Non-Votes Clifford Starke 7,329,521 1,500,756 20,277 4,127,339 Sammy Dorf 8,014,311 815,247 20,996 4,127,339 Edward Woo 8,622,354 204,155 24,045 4,127,339 Manfred Leventhal 8,715,612 114,001 20,941 4,127,339 Harold Wolkin 8,560,356 264,945 25,253 4,127,339   Proposal 2: Reappointment of Davidson & Company LLP, an independent registered public accounting firm, as auditors of the Company for the fiscal year ending December 31, 2025 and authorization of the Board to fix their renumeration.

    https://images.financialmodelingprep.com/news/flora-growth-corp-reports-2024-financial-results-20250324.jpg
    Flora Growth Corp. Reports 2024 Financial Results

    newsfilecorp.com

    2025-03-24 16:05:00

    Fort Lauderdale, Florida--(Newsfile Corp. - March 24, 2025) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") reported today its financial and operating results for the year ended December 31, 2024. "The re-election of President Donald Trump presents a renewed opportunity for meaningful cannabis reform in the United States.

    https://images.financialmodelingprep.com/news/flora-announces-appointment-of-patrick-moloney-as-head-of-20250211.jpg
    Flora Announces Appointment of Patrick Moloney as Head of Product Development for Vessel

    newsfilecorp.com

    2025-02-11 08:30:00

    Fort Lauderdale, Florida--(Newsfile Corp. - February 11, 2025) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is pleased to announce the appointment of Patrick Moloney as Head of Product Development for its accessory brand, Vessel. Mr. Moloney brings over two decades of product innovation and leadership experience, having held senior roles in product development at several globally recognized companies.

    https://images.financialmodelingprep.com/news/clifford-starkes-holdings-in-flora-growth-corp-20241217.jpg
    Clifford Starke's Holdings in Flora Growth Corp.

    newsfilecorp.com

    2024-12-17 18:43:46

    Panama City, Panama--(Newsfile Corp. - December 17, 2024) - On December 15, 2024, Flora Growth Corp.'s Board of Directors granted Clifford Starke (the "Acquiror") 900,000 Restricted Stock Awards which fully vested on December 15, 2024 (the "Acquisition"). Immediately before the completion of the Acquisition, the Acquiror owned an aggregate of 1,346,902 Common Shares, representing approximately 7.80% of the outstanding Common Shares of the Issuer.

    https://images.financialmodelingprep.com/news/flora-growth-corp-announces-closing-of-36-million-registered-20241216.jpg
    Flora Growth Corp. Announces Closing of $3.6 Million Registered Direct Offering

    newsfilecorp.com

    2024-12-16 13:02:00

    Fort Lauderdale, Florida--(Newsfile Corp. - December 16, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (the "Company") today announced the closing of a registered direct offering to institutional investors for the aggregate purchase and sale of approximately $3.6 million of Common Shares at a price of $1.25 per Common Share. The offering consisted of the sale of an aggregate of 2,850,000 Common Shares.

    https://images.financialmodelingprep.com/news/flora-growth-corp-announces-pricing-of-36-million-registered-20241213.jpg
    Flora Growth Corp. Announces Pricing of $3.6 Million Registered Direct Offering

    newsfilecorp.com

    2024-12-13 09:00:00

    Fort Lauderdale, Florida--(Newsfile Corp. - December 13, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (the "Company") today announced that it has entered into definitive agreements in a registered direct offering with institutional investors for the purchase and sale of approximately $3.6 million of Common Shares at a price of $1.25 per Common Share. The offering consists of the sale of 2,850,000 Common Shares.

    https://images.financialmodelingprep.com/news/flora-growth-applauds-launch-of-german-cannabis-pilot-programs-20241212.jpg
    Flora Growth Applauds Launch of German Cannabis Pilot Programs

    newsfilecorp.com

    2024-12-12 08:17:00

    Flora Intends to Submit Applications for Upcoming Cannabis Pilot Programs Run by BMEL Fort Lauderdale, Florida--(Newsfile Corp. - December 12, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") today announced its intention to submit applications for participation in upcoming cannabis pilot programs in Germany to the Federal Ministry for Agriculture and Food ("BMEL"). These programs aim to effectively reduce the illicit market, expand health prevention, and provide an objective foundation for ongoing discussions surrounding cannabis.

    https://images.financialmodelingprep.com/news/flora-growths-peak-usa-celebrates-the-launch-of-thcinfused-20241211.jpg
    Flora Growth's Peak USA Celebrates the Launch of THC-Infused Beverage Brand, Melo, in Total Wines & More

    newsfilecorp.com

    2024-12-11 08:29:00

    Melo Available in Grapefruit, Half & Half Lemonade Iced Tea, Strawberry Mango, and Wild Berry Flavors Fort Lauderdale, Florida--(Newsfile Corp. - December 11, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is proud to announce that its THC-infused beverage brand, Melo, will be available in store in select states beginning Friday December 13th. This beverage is poised to reach a broader audience with imminent placement in the retail networks of Total Wines & More ("Total"), one of the most recognized retailers of innovative and premium alcoholic and non-alcoholic products in the United States.

    https://images.financialmodelingprep.com/news/flora-growth-appoints-sammy-dorf-verano-cofounder-as-executive-chairman-20241210.jpg
    Flora Growth Appoints Sammy Dorf, Verano Co-Founder, as Executive Chairman

    newsfilecorp.com

    2024-12-10 08:35:00

    Adds Verano Co-Founder to its Board as it Accelerates its Entry into the THC-Infused Beverage Market Fort Lauderdale, Florida--(Newsfile Corp. - December 10, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is delighted to announce the appointment of Sammy Dorf, a celebrated pioneer in the cannabis industry, as Executive Chairman of its Board of Directors. This strategic appointment ushers in an exciting new chapter as Flora expands its footprint in the growing THC-infused beverage market and bolsters its global licensing initiatives.

    https://images.financialmodelingprep.com/news/flora-to-launch-bitcoin-payment-integration-20241204.jpg
    Flora to Launch Bitcoin Payment Integration

    newsfilecorp.com

    2024-12-04 09:17:00

    Fort Lauderdale, Florida--(Newsfile Corp. - December 4, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") announced today its intent to explore the integration of Bitcoin as an accepted form of payment across its business platforms. This move aligns with the Company's commitment to innovation and meeting the evolving preferences of its global customer base.

    https://images.financialmodelingprep.com/news/flora-launches-limited-edition-compass-rise-crimson-perfectly-timed-for-20241202.jpg
    Flora Launches Limited Edition Compass Rise Crimson, Perfectly Timed for the Holiday Season

    newsfilecorp.com

    2024-12-02 09:17:00

    Fort Lauderdale, Florida--(Newsfile Corp. - December 2, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is thrilled to announce the launch of the limited-edition Compass Rise Crimson. This exclusive offering, a new addition to the acclaimed Compass Rise Series, is available just in time for the holidays, promising the perfect blend of elegance and functionality for enthusiasts.

    https://images.financialmodelingprep.com/news/flora-expands-european-success-with-thriving-partnership-in-czech-20241126.jpg
    Flora Expands European Success with Thriving Partnership in Czech Republic and Slovakia

    newsfilecorp.com

    2024-11-26 09:17:00

    Fort Lauderdale, Florida--(Newsfile Corp. - November 26, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is pleased to announce it has renewed its sales orders for the Czech Republic and Slovakia through one of Just Brands UK's largest customers, Mirfa s.r.o. ("Mirfa") This long-standing partnership, valued at total demand of approximately $500,000 annually, underscores Flora's commitment to expanding its footprint in high-growth international markets.

    https://images.financialmodelingprep.com/news/flora-unveils-element-revolutionizing-glass-bubbler-20241121.jpg
    Flora Unveils Element, Revolutionizing Glass Bubbler

    newsfilecorp.com

    2024-11-21 08:29:00

    Fort Lauderdale, Florida--(Newsfile Corp. - November 21, 2024) - Flora Growth Corp. (NASDAQ: FLGC) (FSE: 7301) ("Flora" or the "Company") is proud to announce the launch of Element, the latest innovation from its premium lifestyle brand, Vessel. A first-of-its-kind glass and brass bubbler, Element is a cutting-edge addition to Vessel's product lineup.